A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver disease
Dana Ivancovsky‐Wajcman(Global Health Council), Jeffrey V. Lazarus(The Graduate Center, CUNY), Alina M. Allen(Mayo Clinic in Arizona), Javier Crespo(Universidad de Cantabria), Lynn H. Gerber(Global Health Council), John Dillon(Mayo Clinic), Christopher J. Byrne(NHS Tayside), Zobair M. Younossi(Georgetown University), Marcela Villota‐Rivas(Barcelona Institute for Global Health), Paul Brennan(University of Dundee)
Cited by 29
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k